![]() | |
Identifiers | |
---|---|
| |
PubChem CID | |
Chemical and physical data | |
Formula | C30H39NO6 |
Molar mass | 509.643 g·mol−1 |
3D model (JSmol) | |
| |
|
THC valine hemisuccinate (THC-VHS, NB-1111, SBI-100) is a synthetic prodrug of tetrahydrocannabinol, developed at the University of Mississippi as a stabilised formulation for ophthalmic administration, for use in the treatment of glaucoma and other eye conditions requiring reduction in intraocular pressure.[1][2][3][4][5]